Pfizer plans to transfer staff, but not facilities, to Icon as part of the outsourcing deal struck by the companies. Icon intends to hire 600 to 800 staff to cope with the increased workload and some of these could come from Pfizer. However, facilities, such as the site in Sandwich, UK, are of no interest to Icon. “Our core business, the running of Phase II-IV clinical trials, is not a facilities business”, Peter Gray, CEO of Icon, told a conference call with analysts. In contrast, Gray said: “We have talked and provided in our agreements with Pfizer, significantly, for the potential for us to take employees.”